Semaglutide Lawsuit Attorneys

Weight Loss Drugs Linked to Stomach Paralysis

A growing well of research, data, and patient testimonials shows that Ozempic, Wegovy, and Mounjaro are all linked to higher-than-normal risks of stomach paralysis. Hundreds or possibly thousands of people nationwide who have used these diabetes and weight loss drugs have suffered stomach paralysis symptoms despite having no prior risk of this condition. The conclusion among medical experts is that these drugs have an unusually high risk of causing gastroparesis; although, this conclusion has not been confirmed by the Food and Drug Administration (FDA).

Dangerous Symptoms of Stomach Paralysis

Stomach paralysis is a serious medical condition involving weakened or paralyzed stomach muscles and nerves. As a result, the stomach struggles to digest food properly, which leaves undigested food in the stomach for excessive amounts of time, rather than readily passing it to the intestines for continued digestion.

Common symptoms of stomach paralysis include:

• Frequent or chronic indigestion
• Bloated stomach or abdomen
• Inability to eat more than a few bites
• Weak or absent appetite
• Chronic heartburn or acid reflux
• Malnourishment and dehydration
• Abdominal pain
• Nausea or vomiting shortly after eating
• Spitting up whole pieces of food
• Constipation or painful bowel movements
• Unusual blood sugar changes

In severe cases, gastroparesis may cause an intestinal blockage that can become life-threatening if not treated quickly. When this symptom occurs, corrective surgery may be necessary, which always carries its own set of risks and possible side effects.

Why are Drugmakers Being Sued?

Novo Nordisk is the maker of Ozempic and Wegovy, and it is at the center of most semaglutide lawsuits that have formed or are forming. According to the complaints and research into the situation, the drugmaker knew or should have known that the type II diabetes medication had an inordinately high risk of causing stomach paralysis. Yet the drugmaker – and others who have produced similar drugs – did not warn the medical community or the public of this risk.

Two legal concepts may allow Novo Nordisk and other drugmakers to be held liable for the harm caused by Ozempic and other drugs:

1. Product liability: Typically, product liability laws allow an injured consumer to hold a product manufacturer strictly liable for any harm that their product caused, which includes medications made by Big Pharma. 
2. General or gross negligence: If the allegations against Novo Nordisk are true, and the drugmaker did not warn of the drug’s risk of gastroparesis, the company could be accused of negligence at best or intentional wrongdoing at worst. Both could make the company liable for the losses suffered by Ozempic and Wegovy users.

Is There an Ozempic Class Action?

Dozens of Ozempic lawsuits have been added to a class action multidistrict litigation (MDL) case. If you were hurt by Ozempic, your case may be eligible to join a pre-existing class action lawsuit. Or your case may be handled on an individual basis if it includes highly specific or unique circumstances. In either situation, Matthews & Associates will be ready to represent and guide you through any legal processes, so you can feel confident that your case is being handled correctly.

We Represent People Across the U.S. – Call Now

Don’t delay if you or a loved one suffered stomach paralysis after using semaglutide-based diabetes or weight loss medications like Wegovy and Ozempic. Legal action is already forming against the makers of these drugs, and you don’t want to miss your chance to speak up and demand compensation for your suffering. Come to Matthews & Associates today and start exploring your legal options with a professional team.

We take Ozempic cases nationwide. Call (888) 923-7001 for a FREE case evaluation.